InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Finished Goods (2023 - 2025)

InflaRx (IFRX) posted Finished Goods of $60874.5 for Q2 2025, up 0.6% sequentially from $60511.4 in Q4 2024, and up 21.41% YoY from $50138.8 in Q2 2024.

InflaRx (IFRX) Finished Goods (2023 - 2025) Analysis & Trends

InflaRx has reported Finished Goods for 3 years, with the latest figure at $60874.5 in Q2 2025.

  • Quarterly Finished Goods rose 21.41% year-over-year to $60874.5 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $60874.5 (up 21.41% YoY) and the FY2024 annual result came in at $61289.6, down 82.83% from the prior year.
  • Finished Goods improved to $60874.5 in Q2 2025 per IFRX's latest filing, from $60511.4 in the prior quarter.
  • Over five years, Finished Goods peaked at $286.4 billion in Q3 2023 and troughed at $50138.8 in Q2 2024.
  • A 3-year average of $57.3 billion and a median of $60874.5 in 2025 frame the typical range for Finished Goods.
  • The sharpest annual moves came in 2024 and 2025: Finished Goods sank 82.96% in 2024, then grew 21.41% in 2025.
  • Over 3 years, Finished Goods stood at $355153.8 in 2023, then tumbled by 82.96% to $60511.4 in 2024, then advanced by 0.6% to $60874.5 in 2025.
  • According to Business Quant data, Finished Goods over the past three periods registered $60874.5, $60511.4, and $50138.8 for Q2 2025, Q4 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn

Historic Data

Download Data
DateValue
Jun 30, 2025 60,874.53
Dec 31, 2024 60,511.35
Jun 30, 2024 50,138.81
Dec 31, 2023 355,153.78
Sep 30, 2023 286.43 Bn